BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 20524422)

  • 1. Kinetic modeling on drug release from controlled drug delivery systems.
    Dash S; Murthy PN; Nath L; Chowdhury P
    Acta Pol Pharm; 2010; 67(3):217-23. PubMed ID: 20524422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the Refined Integral Method in the mathematical modeling of drug delivery from one-layer torus-shaped devices.
    Helbling IM; Ibarra JC; Luna JA
    Int J Pharm; 2012 Feb; 423(2):240-6. PubMed ID: 22178126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols.
    Salama RO; Traini D; Chan HK; Young PM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):145-52. PubMed ID: 18534832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure.
    Dokoumetzidis A; Macheras P
    J Control Release; 2008 Jul; 129(2):76-8. PubMed ID: 18538435
    [No Abstract]   [Full Text] [Related]  

  • 8. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs.
    Huang WC; Hu SH; Liu KH; Chen SY; Liu DM
    J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid bed coating: the utility of dual programmable pumps for controlled gradient drug deposition on pellets.
    El-Malah Y; Nazzal S
    Int J Pharm; 2007 Jun; 337(1-2):361-4. PubMed ID: 17289315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling of drug delivery.
    Siepmann J; Siepmann F
    Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogels in controlled release formulations: network design and mathematical modeling.
    Lin CC; Metters AT
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
    Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S; Takayama K
    Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.